SCHEMBL14601272

SCHEMBL14601272

CC1CCN(C(=O)c2cccc(CI)c2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.61
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ HPGD P15428 5/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ TP53 P04637 1/20 0.56
▸ KMT2A Q03164 2/20 0.54
▸ PDE3B Q13370 1/20 0.52
▸ PDE3A Q14432 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ PARP1 P09874 1/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ GRM5 P41594 1/20 0.49
▸ L3MBTL3 Q96JM7 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ MAPT P10636 1/20 0.47
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13663681 0.86 ACHE (0.61) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL10724144 0.85 ACHE (0.77) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL18551055 0.83 SMN1; SMN2 (0.57) NPC1RAB9AHPGDALDH1A1TP53
SCHEMBL5047494 0.81 ACHE (0.67) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL8054515 0.80 HPGD (0.69) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL23440304 0.78 ALDH1A1 (0.73) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL9500165 0.78 ACHE (0.67) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL28855327 0.78 ACHE (0.67) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL13504099 0.78 SMN1; SMN2 (0.68) ACHENPC1RAB9AHPGDALDH1A1
SCHEMBL23440265 0.77 ACHE (0.74) ACHENPC1RAB9AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 — — WO disclosed
Send feedback